C-reactive protein in COVID-19 patients

Abstract

This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.

The role of the neutrophil-lymphocyte ratio in predicting poor outcomes in COVID-19 patients

“…The inflammatory response can be used as a diagnostic tool to determine the severity and scope of COVID-19. Serum lactate dehydrogenase [ 15 ], ferritin [ 16 ], C-reactive protein [ 17 ], D-dimer [ 18 ], and interleukin-6 are representative examples of inflammatory markers that have demonstrated a robust association with elevated susceptibility to severe COVID-19 [ 15 , 16 , 19 ]. Neutrophils and lymphocytes are integral cellular constituents of the immune system, and their involvement in the pathophysiology of various diseases is of paramount importance [ 20 , 21 ].…”